Poor Quality of Warfarin Treatment Increases the Risk of All Types of Intracranial Hemorrhage in Atrial Fibrillation

Autor: Pekka Raatikainen, Mika Lehto, Houssem Khanfir, Jukka Putaala, Paula Tiili, Juha Mehtälä, Jussi Niiranen, Pasi K. Korhonen
Přispěvatelé: Kardiologian yksikkö, Department of Medicine, Clinicum, Department of Neurosciences, Neurologian yksikkö, HUS Heart and Lung Center, HUS Neurocenter
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
INR
medicine.medical_specialty
Anemia
INTRACEREBRAL HEMORRHAGE
ADVANCED AGE
Intracranial hemorrhage
030204 cardiovascular system & hematology
03 medical and health sciences
Anticoagulation
0302 clinical medicine
Risk Factors
Internal medicine
medicine
Humans
Registries
030212 general & internal medicine
cardiovascular diseases
THERAPEUTIC RANGE
ANEMIA
Stroke
Finland
Aged
Retrospective Studies
Intracerebral hemorrhage
business.industry
INTENSITY
THROMBOEMBOLIC EVENTS
MORTALITY
Hazard ratio
Warfarin
Atrial fibrillation
General Medicine
medicine.disease
3. Good health
nervous system diseases
3121 General medicine
internal medicine and other clinical medicine

Cohort
ANTICOAGULATION CONTROL
Female
Cardiology and Cardiovascular Medicine
Complication
business
Intracranial Hemorrhages
STROKE
medicine.drug
Popis: Background Intracranial hemorrhage (ICH) is a devastating complication of oral anticoagulation. The aim of this study was to describe the spectrum of ICH and to evaluate the association of warfarin control with the risk of ICH in a nationwide cohort of unselected atrial fibrillation (AF) patients. Methods and Results: The FinWAF is a retrospective registry-linkage study. Data were collected from several nationwide Finnish health-care registers and laboratory databases. The primary outcome was any ICH (traumatic or non-traumatic). The quality of warfarin therapy was assessed continuously by calculating the time in therapeutic range in a 60-day window (TTR60). Adjusted Cox proportional hazard models were used. A total of 53,953 patients were included (53% men; mean age, 73 years; mean follow-up, 2.94 years; mean TTR, 63%). In 129,684 patient-years, 1,196 patients had ICH (non-traumatic, 53.5%; traumatic, 43.6%; traumatic subdural, 38.6%); crude annual rate, 0.92%; 95% CI: 0.87-0.98). A lower TTR60 was significantly associated with higher risk of ICH (TTR60 ≤40% vs. TTR60 >80%; adjusted hazard ratio, 2.16; 95% CI: 1.83-2.54). Other variables independently associated with ICH included age >65 years, previous stroke, male sex, low hemoglobin, thrombocytopenia, elevated alanine aminotransferase, and previous bleeding other than ICH. Conclusions Poor control of warfarin treatment was associated with elevated risk of ICH. Approximately half of the ICH were traumatic, mainly subdural.
Databáze: OpenAIRE